Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05350319 · ClinicalTrials.gov registry record
Prospective Low Dose CT for Total Shoulder Arthroplasty/Reverse Shoulder Arthroplasty
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 20
- Enrollment target
NCT05350319: Completed study, sponsored by Duke University.
NCT05350319 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05350319 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This study is a prospective, departmental funded study examining the outcomes of simulated Low Dose CT scans compared to Conventional Dose CT scans in patients who present to Duke University for total shoulder arthroplasty or reverse shoulder arthroplasty.
Primary Outcome
Low Dose CT Images will be compared to a standard dose to assess image quality.
Interventions
- RADIATION A low-dose CT scan of the shoulder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2023-09-19 |
What the finished NCT05350319 record still lists
NCT05350319 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which A low-dose CT scan of the shoulder is the first listed.
NCT05350319 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05350319 about?
NCT05350319 is a clinical study titled "Prospective Low Dose CT for Total Shoulder Arthroplasty/Reverse Shoulder Arthroplasty". This study is a prospective, departmental funded study examining the outcomes of simulated Low Dose CT scans compared to Conventional Dose CT scans in patients who present to Duke University for total shoulder arthroplasty or reverse shoulder arthroplasty.
What is the current status of trial NCT05350319?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2022-11-21. Estimated completion is 2023-09-19.
What interventions are being tested in trial NCT05350319?
The interventions under investigation include: A low-dose CT scan of the shoulder (RADIATION).
Who is sponsoring clinical trial NCT05350319?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI